Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Despotis

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Anesthesia and Analgesia|September 20, 1997
Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activationG J Despotis, V Levine, J H Joist, et al.
Anesthesia and Analgesia|June 1, 1996
Aprotinin prolongs activated and nonactivated whole blood clotting time and potentiates the effect of heparin in vitroG J Despotis, K S Filos, V Levine, et al.
Anesthesia and Analgesia|March 1, 1997
Hemofiltration during cardiopulmonary bypass: the effect on anti-Xa and anti-IIa heparin activityG J Despotis, V Levine, K S Filos, et al.
The Annals of Thoracic Surgery|March 1, 1996
Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin dosesG J Despotis, A L Alsoufiev, E Spitznagel, et al.
Thrombosis Research|May 1, 1997
Effects of platelets and white blood cells and antiplatelet agent C7E3 (Reopro) on a new test of PAF procoagulant activity of whole bloodG J Despotis, S Ikonomakou, V Levine, et al.
Critical Care Medicine|October 1, 1995
Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitorG J Despotis, C W Hogue, S A Santoro, et al.
Anesthesia and Analgesia|January 1, 1996
Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patientsG J Despotis, K S Filos, T N Zoys, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 1, 1994
Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operationG J Despotis, S A Santoro, E Spitznagel, et al.
Seminars in Thoracic and Cardiovascular Surgery|June 23, 1999
Effects of nicardipine and nitroglycerin on perioperative myocardial ischemia in patients undergoing coronary artery bypass surgeryI Apostolidou, N J Skubas, A Bakola, et al.
Anesthesia and Analgesia|June 29, 2001
The relationship between hirudin and activated clotting time: implications for patients with heparin-induced thrombocytopenia undergoing cardiac surgeryG J Despotis, C W Hogue, R Saleem, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Anesthesia and Analgesia|September 20, 1997
Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activationG J Despotis, V Levine, J H Joist, et al.
Anesthesia and Analgesia|June 1, 1996
Aprotinin prolongs activated and nonactivated whole blood clotting time and potentiates the effect of heparin in vitroG J Despotis, K S Filos, V Levine, et al.
Anesthesia and Analgesia|March 1, 1997
Hemofiltration during cardiopulmonary bypass: the effect on anti-Xa and anti-IIa heparin activityG J Despotis, V Levine, K S Filos, et al.
The Annals of Thoracic Surgery|March 1, 1996
Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin dosesG J Despotis, A L Alsoufiev, E Spitznagel, et al.
Thrombosis Research|May 1, 1997
Effects of platelets and white blood cells and antiplatelet agent C7E3 (Reopro) on a new test of PAF procoagulant activity of whole bloodG J Despotis, S Ikonomakou, V Levine, et al.
Critical Care Medicine|October 1, 1995
Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitorG J Despotis, C W Hogue, S A Santoro, et al.
Anesthesia and Analgesia|January 1, 1996
Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patientsG J Despotis, K S Filos, T N Zoys, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 1, 1994
Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operationG J Despotis, S A Santoro, E Spitznagel, et al.
Seminars in Thoracic and Cardiovascular Surgery|June 23, 1999
Effects of nicardipine and nitroglycerin on perioperative myocardial ischemia in patients undergoing coronary artery bypass surgeryI Apostolidou, N J Skubas, A Bakola, et al.
Anesthesia and Analgesia|June 29, 2001
The relationship between hirudin and activated clotting time: implications for patients with heparin-induced thrombocytopenia undergoing cardiac surgeryG J Despotis, C W Hogue, R Saleem, et al.
Pageof 5